NCT03984448 2026-05-13Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell LymphomasNational Cancer Institute (NCI)Phase 2/3 Active not recruiting363 enrolled
NCT02405676 2026-03-19BNHL-2015Children's Cancer Group, ChinaPhase 2/3 Active not recruiting200 enrolled